Does CALASPARGASE PEGOL Cause Hypertriglyceridaemia? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Hypertriglyceridaemia have been filed in association with CALASPARGASE PEGOL (asparlas). This represents 21.6% of all adverse event reports for CALASPARGASE PEGOL.
27
Reports of Hypertriglyceridaemia with CALASPARGASE PEGOL
21.6%
of all CALASPARGASE PEGOL reports
9
Deaths
24
Hospitalizations
How Dangerous Is Hypertriglyceridaemia From CALASPARGASE PEGOL?
Of the 27 reports, 9 (33.3%) resulted in death, 24 (88.9%) required hospitalization, and 9 (33.3%) were considered life-threatening.
Is Hypertriglyceridaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CALASPARGASE PEGOL. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does CALASPARGASE PEGOL Cause?
Febrile neutropenia (19)
Hypersensitivity (13)
Neutropenia (11)
Coagulopathy (10)
Hepatotoxicity (10)
Renal failure (10)
Circulatory collapse (9)
Clostridium difficile infection (9)
Electrolyte imbalance (9)
Gastrointestinal haemorrhage (9)
What Other Drugs Cause Hypertriglyceridaemia?
PEGASPARGASE (399)
VINCRISTINE (373)
METHOTREXATE (372)
DEXAMETHASONE (358)
CYTARABINE (244)
CYCLOPHOSPHAMIDE (191)
QUETIAPINE (181)
MERCAPTOPURINE (176)
PREDNISONE (161)
DAUNORUBICIN (143)
Which CALASPARGASE PEGOL Alternatives Have Lower Hypertriglyceridaemia Risk?
CALASPARGASE PEGOL vs CALASPARGASE PEGOL-MKNL
CALASPARGASE PEGOL vs CALCIFEDIOL
CALASPARGASE PEGOL vs CALCIPOTRIENE
CALASPARGASE PEGOL vs CALCITONIN
CALASPARGASE PEGOL vs CALCITONIN SALMON